Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Operating Expenses (2019)

Neurogene's Other Operating Expenses history spans 1 years, with the latest figure at $4.9 million for Q4 2019.

  • For Q4 2019, Other Operating Expenses changed N/A year-over-year to $4.9 million; the TTM value through Sep 2020 reached $4.9 million, down 89.63%, while the annual FY2019 figure was $47.7 million, N/A changed from the prior year.
  • Other Operating Expenses reached $4.9 million in Q4 2019 per NGNE's latest filing, down from $49.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $49.1 million in Q3 2019 to a low of -$2.0 million in Q2 2019.